BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I

Clinical trial NCT00876460 · COMPLETED

Trial details

NCT number: NCT00876460
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2009-03-01
Primary completion: 2012-09-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.